Breakthrough drug trial aims to stop deadly blood clots in ICU patients
NCT ID NCT07214103
Summary
This study is testing whether a drug called sivelestat can help restore normal blood clotting in ICU patients with septic shock who develop dangerous blood clotting problems. The trial will involve 120 patients who will receive either the drug or a placebo to see if sivelestat improves their blood's ability to dissolve clots. Researchers hope this treatment could help prevent organ damage and improve survival in this life-threatening condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.